Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.650
-0.040 (-2.37%)
At close: Feb 11, 2026, 4:00 PM EST
1.680
+0.030 (1.82%)
After-hours: Feb 11, 2026, 7:36 PM EST
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $370.8 million as of February 11, 2026. Its market cap has decreased by -8.37% in one year.
Market Cap
370.80M
Enterprise Value
206.00M
1-Year Change
-8.37%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $370.80M, a decrease of -87.13%. That is a compound annual growth rate of -24.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 373.05M | 21.17% |
| Dec 31, 2025 | 307.88M | -31.06% |
| Dec 31, 2024 | 446.60M | -17.32% |
| Dec 29, 2023 | 540.17M | -40.45% |
| Dec 30, 2022 | 907.08M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entrada Therapeutics | 396.63M |
| PepGen | 393.93M |
| Absci | 390.97M |
| NovaBridge Biosciences | 390.84M |
| Greenwich LifeSciences | 384.19M |
| Bicycle Therapeutics | 383.26M |
| Autolus Therapeutics | 380.58M |
| Aclaris Therapeutics | 367.29M |